MOROSINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.981
AS - Asia 1.353
EU - Europa 1.194
SA - Sud America 244
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 1
Totale 4.880
Nazione #
US - Stati Uniti d'America 1.928
CN - Cina 620
SG - Singapore 291
IE - Irlanda 265
BR - Brasile 199
RU - Federazione Russa 152
FI - Finlandia 149
HK - Hong Kong 148
DE - Germania 146
VN - Vietnam 144
IT - Italia 117
UA - Ucraina 113
GB - Regno Unito 69
FR - Francia 64
SE - Svezia 45
ZA - Sudafrica 41
IN - India 37
CA - Canada 30
BD - Bangladesh 26
JP - Giappone 22
PL - Polonia 16
MX - Messico 15
AR - Argentina 14
IQ - Iraq 13
EC - Ecuador 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
CO - Colombia 7
ES - Italia 7
ID - Indonesia 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
LT - Lituania 6
SA - Arabia Saudita 5
AL - Albania 4
CL - Cile 4
DZ - Algeria 4
MA - Marocco 4
UZ - Uzbekistan 4
VE - Venezuela 4
AT - Austria 3
CH - Svizzera 3
EU - Europa 3
PK - Pakistan 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DK - Danimarca 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
EG - Egitto 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.836
Città #
Dublin 265
Chandler 246
Ashburn 207
San Jose 195
Singapore 163
Beijing 151
Hong Kong 145
Dallas 136
Jacksonville 133
Nanjing 91
Boardman 72
Los Angeles 71
Helsinki 68
New York 65
Munich 46
Council Bluffs 45
Ho Chi Minh City 43
Princeton 40
Johannesburg 39
Pavia 39
Lauterbourg 37
Lawrence 37
Nanchang 37
Shenyang 35
Hanoi 33
Hebei 30
Shanghai 30
Wilmington 30
Changsha 29
Turku 29
Medford 28
Jiaxing 23
Moscow 23
Tokyo 21
São Paulo 20
Hangzhou 18
Santa Clara 18
Buffalo 17
Milan 17
Ann Arbor 16
Tianjin 16
Orem 14
Seattle 14
Warsaw 14
Montreal 13
Redondo Beach 13
Verona 13
Washington 13
Brooklyn 12
Houston 12
London 12
The Dalles 12
Columbus 11
Poplar 10
Toronto 10
Woodbridge 10
Frankfurt am Main 9
Belo Horizonte 8
Da Nang 8
Atlanta 7
Baghdad 7
Brussels 7
Fairfield 7
Haiphong 7
Manchester 7
Piscataway 7
Biên Hòa 6
Chennai 6
Denver 6
Nuremberg 6
Phoenix 6
Rio de Janeiro 6
San Francisco 6
Stockholm 6
Zhengzhou 6
Amsterdam 5
Mexico City 5
Mumbai 5
Ningbo 5
Ninh Bình 5
Vũng Tàu 5
Auburn Hills 4
Berlin 4
Chicago 4
Falkenstein 4
Hải Dương 4
Norwalk 4
São José dos Campos 4
Taizhou 4
Tashkent 4
Ankara 3
Aracaju 3
Augusta 3
Bari 3
Boston 3
Brasília 3
Brescia 3
Caracas 3
Casablanca 3
Curitiba 3
Totale 3.211
Nome #
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 178
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 169
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 160
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 157
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 151
Specific Anti-CMV Reactivity in BAL: A Useful Tool 146
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 141
Regulatory T cells in kidney transplant recipients. 140
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 139
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 133
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 132
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 132
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 130
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 130
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 130
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 129
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 128
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 127
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 125
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 125
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 124
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 122
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 118
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 118
Possible Disease Markers in BAL Fluid of BOS Patients 111
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 111
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 110
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 108
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 106
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 105
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 100
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 99
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 98
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 91
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 91
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 86
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 84
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 83
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 78
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis 69
Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD 66
Totale 4.880
Categoria #
all - tutte 19.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 4 3 0 2 2 6 10 6 25 84
2022/2023704 70 65 2 56 60 73 0 36 309 6 18 9
2023/2024364 58 60 17 14 24 95 8 31 1 20 14 22
2024/2025870 23 46 21 30 23 88 66 65 201 19 102 186
2025/20261.804 151 86 201 213 256 99 339 85 159 109 56 50
2026/202775 27 48 0 0 0 0 0 0 0 0 0 0
Totale 4.880